# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://x.com/PatentGrants/status/1944848362106462423
-SEC Filing
InMed stock jumped after preclinical data showed INM-901 lowered brain inflammation tied to Alzheimer's and improved cognit...
INM: 102% | InMed shares are trading higher after the company announced preclinical data showing INM-901 reduced neuroinflammat...